Causes and Predictors of Early Hospital Readmission in Systemic Lupus Erythematosus
Overview
Affiliations
Objective: We investigated characteristics of adult patients with systemic lupus erythematosus (SLE) readmitted to the hospital within 30 days of discharge, in an attempt to identify the causes of early readmission.
Methods: We performed a retrospective case-control study examining all inpatient electronic health records of patients with SLE at Cedars-Sinai Medical Center over a 2.5-year period (2012-2014). Patients were included if they had an International Classification of Diseases, 9th ed diagnosis of SLE and were readmitted within 30 days of their initial hospitalization. Patients with SLE not readmitted during this time period were used as a control group. Demographic and clinical variables for each patient were collected, and we used the Charlson Comorbidity Index to characterize comorbidities. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) was used to assess the chronic damage of SLE. Stepwise multivariable logistic regression analysis was used to predict factors associated with readmission.
Results: In total, 570 hospitalizations representing 455 unique patients met our inclusion and exclusion criteria. Of these, 154 patients (34%) underwent readmission within 30 days of their initial hospitalization. Patients in the early readmission group were more likely to have government-sponsored Medicaid insurance and were significantly associated with an increased SDI (OR 1.27, 95% CI 1.1-1.48), lower serum hemoglobin (OR 0.82, 95% CI 0.72-0.93), and lower serum albumin (OR 0.66, 95% CI 0.47-0.91).
Conclusion: One-third of hospitalized patients with SLE were readmitted within 30 days at our institution. We identified characteristics of this at-risk population at time of discharge with high specificity, in hopes of reducing this costly outcome.
Fagbenro A, Amadi E, Uwumiro F, Nwebonyi S, Edwards Q, Okere M Cureus. 2024; 16(11):e73099.
PMID: 39650958 PMC: 11621573. DOI: 10.7759/cureus.73099.
Pons-Estel G, Quintana R, Ugarte-Gil M, Harvey G, Wojdyla D, Serrano-Morales R Lupus. 2024; 33(13):1492-1501.
PMID: 39259025 PMC: 11487867. DOI: 10.1177/09612033241283551.
Schletzbaum M, Sweet N, Astor B, Yu A, Powell W, Gilmore-Bykovskyi A Arthritis Care Res (Hoboken). 2023; 75(9):1886-1896.
PMID: 36752354 PMC: 10406973. DOI: 10.1002/acr.25097.
Prevalence of hospital readmissions and related factors in patients with autoimmune diseases.
Morales-Tisnes T, Quintero-Ortiz L, Quintero-Munoz E, Sierra-Matamoros F, Arias-Aponte J, Rojas-Villarraga A J Transl Autoimmun. 2021; 4:100121.
PMID: 34585131 PMC: 8450261. DOI: 10.1016/j.jtauto.2021.100121.
Bartels C, Chodara A, Chen Y, Wang X, Powell W, Shi F Semin Arthritis Rheum. 2021; 51(2):477-485.
PMID: 33813261 PMC: 8106659. DOI: 10.1016/j.semarthrit.2021.02.006.